Neokacin
FEATURES
Loading...
NAMES
  • Neokacin
SMILES
NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2N)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O[C@@H]3O[C@H](CN)[C@H](O)[C@@H](O)[C@@H]3N)[C@H]2O)[C@H]1O
InChI
InChI=1S/C27H53N7O15/c28-2-1-9(36)24(43)34-8-3-7(31)21(47-25-13(32)18(40)16(38)10(4-29)44-25)23(15(8)37)49-27-20(42)22(12(6-35)46-27)48-26-14(33)19(41)17(39)11(5-30)45-26/h7-23,25-27,35-42H,1-6,28-33H2,(H,34,43)/t7-,8+,9-,10+,11+,12+,13+,14-,15-,16+,17-,18+,19-,20+,21+,22+,23+,25+,26-,27-/m0/s1
MOLECULAR FORMULA
C27H53N7O15
CROSS REFERENCES
Loading...
Neokacin
Compound Synopsis
OVERVIEW
PROPERTIES
Molecular weight715.36
AlogP-10.03
HBond donors21
HBond acceptors22
Atoms102
Contains toxicophoreNo
Contains PAINSNo
Commercially availableUnknown
Property color indications are based on Lipinski's Ro5.
PROTEIN TARGETS
No information about proteins targeted by Neokacin.